| Ref ID | 1054 |
| First Author | G. Sahi |
| Journal | ORTHOPAEDIC TRAUMATOLOGY SURGERY & RESEARCH |
| Year Of Publishing | 2024 |
| URL | https://www.sciencedirect.com/science/article/abs/pii/S1877056823002712?via%3Dihub |
| Keywords |
• Musculoskeletal • Low methodological quality |
| Problem(s) |
• Lack of prespecification in eligibility criteria • Reasons for excluding potentially eligible studies not provided • Conflicts of interest or funding of included studies not assessed • Low methodological (AMSTAR) quality |
| Article Type | Empirical |
| Article Subtype | Cross-sectional survey/Methodological systematic review |
| First Author Country | Canada |
| Checklists |
• AMSTAR 2 |
| Aim | To evaluate the methodological quality of systematic reviews (SRs) indexed across MEDLINE, EMBASE, PubMed and Cochrane databases from inception to May 2023, on platelet-rich-plasma therapy for knee osteoarthritis using AMSTAR 2. |
| Level of Investigation | Descriptive |
| Summary of Findings | From 41 included systematic reviews (SRs) indexed across MEDLINE, EMBASE, PubMed and Cochrane databases from inception to May 2023. Of the 41 SRs included in the analysis none were deemed high quality. Seven SRs (17%) were of “low” quality, while the remainder (34 SRs, 83%) were rated as “critically low”. The least reported items were: 1) 27/41 (65.8%) did not explain their selection of the study designs for inclusion in the review; 2) 37/41 (90.2%) did not provide a list of excluded studies with justifications; 3) 34/41 (82.9%) did not report on the sources of funding for the included studies; 4) 32/41 (78.0%) did not account for risk of bias in individual studies when interpreting/ discussing the results. |
| Number of systematic reviews included | 41 |
| Number of eligible systematic reviews assessed | 576 |
| Treatment impacted | No |
| Treatment impacted description | |
| Interpretation impacted | Not Applicable |
| Interpretation impacted description |